Solid Lipid Nanoparticles: Tuneable Anti-Cancer Gene/Drug Delivery Systems

With the advent of multifunctional nano delivery systems, simultaneous imaging and therapy aspires to detect and treat tumors at a very early stage with promising out‐ comes. In this context, numerous anti-cancer drug/gene delivery systems have been ex‐ plored with the primary aim to increase the treatment efficacy without compromising safety. Secondary goals include enhancing bioavailability, specific targeting, apart from the enhanced stability of the formulation [1]. The multifaceted applications of nanoparti‐ cles are the direct result of their ability to deliver high pay loads of drugs or biomarkers to the desired sites within the body. Design and development of tumor specific nanopar‐ ticles could significantly amplify the delivering capacity to a specific target of interest, without affecting healthy cells [2]. Technological advances in nanomaterials and nano‐ technology have paved the way for several carriers such as liposomes [3], dendrimers [4], and micelles [5], solid lipid nanoparticles (SLN) [6] and recently nanostructured lipid carriers [1, 7]. Polymeric micelles, or nanosized (~10–100 nm) supramolecular constructs composed of amphiphilic block-copolymers, are emerging as powerful drug delivery ve‐ hicles for hydrophobic drugs. Liposomes are currently the most popular nanosized drug delivery systems, with one or several lipid bilayers enclosing an aqueous core. Liposomeencapsulated formulations of doxorubicin earlier approved for the treatment of Kaposi’s sarcoma, are now used against breast cancer and refractory ovarian cancer. Breast cancer in particular has been the focus of many studies involving liposome-based chemothera‐ peutics, in part due to the clinical success of various drugs such as Doxil, which is a lip‐ osomal formulation currently used to treat recurrent breast cancer [7]. The anthracycline doxorubicin is the active cytotoxic agent and is contained within the internal aqueous core of the liposome. The encapsulation of doxorubicin within liposomes significantly re‐

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-02-13

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.5772/54781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector.

  2013cited by this paper
• Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA.

  2012cited by this paper
• Nanostructured lipid carriers system: Recent advances in drug delivery

  2012cited by this paper
• Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

  2012cited by this paper
• Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.

  2012cited by this paper
• Liposomes and nanotechnology in drug development: focus on oncotargets

  2012cited by this paper
• Editorial [ Hot Topic:siRNA Based Approaches in Medicinal Chemistry and Drug Discovery (Guest Editor: Raymond M. Schiffelers )]

  2012cited by this paper
• Solid lipid nanoparticles (SLNs) for topical delivery of aceclofenac by using xanthan gum: Ex vivo and in vivo evaluation.

  2012cited by this paper
• Phospho-Sulindac (OXT-328) Inhibits the Growth of Human Lung Cancer Xenografts in Mice: Enhanced Efficacy and Mitochondria Targeting by its Formulation in Solid Lipid Nanoparticles

  2012cited by this paper
• Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES).

  2012cited by this paper
• PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells

  2012cited by this paper
• Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy.

  2012cited by this paper
• Nanocarriers for dermal drug delivery: influence of preparation method, carrier type and rheological properties.

  2012cited by this paper
• siRNA based approaches in medicinal chemistry and drug discovery.

  2012cited by this paper
• Development of cationic solid lipid nanoparticles with factorial design-based studies for topical administration of doxorubicin.

  2012cited by this paper
• Dendritic nanoparticles: the next generation of nanocarriers?

  2012cited by this paper
• Cellular uptake of DNA-chitosan nanoparticles: the role of clathrin- and caveolae-mediated pathways.

  2012cited by this paper
• Liposomes and nanotechnology in drug development: focus on ocular targets

  2012cited by this paper
• The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process

  2011cited by this paper
• Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration

  2011cited by this paper
• Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies.

  2011cited by this paper
• Recent developments in lipid-based pharmaceutical nanocarriers.

  2011cited by this paper
• Nanostructured materials in drug and gene delivery: a review of the state of the art.

  2011cited by this paper
• A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study.

  2011cited by this paper
• In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.

  2011cited by this paper
• Lipid-based drug delivery systems for cancer treatment.

  2011cited by this paper
• Tryptanthrin-loaded nanoparticles for delivery into cultured human breast cancer cells, MCF7: the effects of solid lipid/liquid lipid ratios in the inner core.

  2011cited by this paper
• Structural investigation and intracellular trafficking of a novel multicomposite cationic solid lipid nanoparticle platform as a pDNA carrier.

  2011cited by this paper
• Design of solid lipid nanoparticles for gene delivery into prostate cancer.

  2010cited by this paper
• Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting.

  2010cited by this paper
• Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: in vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells.

  2010cited by this paper
• Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems

  2010cited by this paper
• pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles.

  2010cited by this paper
• Chemical vectors for gene delivery: uptake and intracellular trafficking.

  2010cited by this paper
• Pharmacokinetics in rats and efficacy in murine ovarian cancer model for solid lipid nanoparticles loading docetaxel.

  2010cited by this paper
• Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System

  2009cited by this paper
• Multifunctional Micellar Nanomedicine for Cancer Therapy

  2009cited by this paper
• Folate receptor mediated intracellular gene delivery using the charge changing solid lipid nanoparticles

  2009cited by this paper
• Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer

  2009cited by this paper
• A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells

  2008cited by this paper
• Polymer-based gene delivery: a current review on the uptake and intracellular trafficking of polyplexes.

  2008cited by this paper
• Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.

  2008influential reference
• Functionalized Solid Lipid Nanoparticles for Transendothelial Delivery

  2008cited by this paper
• [Preparation of solid lipid nanoparticles loaded with Xionggui powder-supercritical carbon dioxide fluid extraction and their evaluation in vitro release].

  2006cited by this paper
• Solid lipid nanoparticles (SLN)--effects of lipid composition on in vitro degradation and in vivo toxicity.

  2006cited by this paper
• Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice.

  2005cited by this paper
• Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.

  2004cited by this paper
• Optimization of Spray-Dried and -Congealed Lipid Micropellets and Characterization of Their Surface Morphology by Scanning Electron Microscopy

  2004cited by this paper
• Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders.

  2004cited by this paper
• Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.

  2004cited by this paper
• Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats.

  2002cited by this paper
• Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

  2002cited by this paper
• Nanoparticles in cancer therapy and diagnosis.

  2002cited by this paper
• Incorporation of cyclosporin A in solid lipid nanoparticles (SLN).

  2002cited by this paper
• Structure and design of polymeric surfactant-based drug delivery systems.

  2001cited by this paper
• Solid lipid nanoparticles: production, characterization and applications.

  2001cited by this paper
• Gaulin Homogenization: A Mechanistic Study

  2000cited by this paper
• Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

  2000cited by this paper
• Spray-drying of solid lipid nanoparticles (SLN TM).

  1998cited by this paper
• Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.

  1998cited by this paper
• Solid-state characterization of paclitaxel.

  1997cited by this paper
• Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions

  1996cited by this paper
• Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate

  1992cited by this paper

• Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy

  2023cites this paper
• Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer

  2022cites this paper
• Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy

  2022cites this paper
• Development of Solid Lipid Nanoparticles with Letrozole for Breast Cancer Treatment: in-vitro and in-vivo evaluation

  2022cites this paper
• Non-Viral Gene Therapy Vectors for Cancer Treatment

  2022cites this paper
• Phthalocyanine-loaded nanostructured lipid carriers functionalized with folic acid for photodynamic therapy.

  2020cites this paper
• Nanoparticles for treatment of bovine Staphylococcus aureus mastitis

  2020cites this paper
• Promoted Antitumor Activity of Myricetin against Lung Carcinoma Via Nanoencapsulated Phospholipid Complex in Respirable Microparticles

  2020cites this paper
• Nanoemulsions Loaded with Amphotericin B: Development, Characterization and Leishmanicidal Activity.

  2019cites this paper
• Lipid-based nanocarriers for breast cancer treatment – comprehensive review

  2016cites this paper
• Nanocarriers Usage for Drug Delivery in Cancer Therapy

  2016cites this paper
• Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: Production, characterization and in vitro studies.

  2015cites this paper
• Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application.

  2015cites this paper
• NANoPARtIcLes As PLAtFoRMs FoR DeLIVeRY oF cURcUMIN

  2015cites this paper
• Functionalized Lipid Particulates in Targeted Drug Delivery

  2015cites this paper
• Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-2

  2015cites this paper
• Physico-chemical characterisation, cytotoxic activity, and biocompatibility studies of tamoxifen-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification method

  2014cites this paper
• NANOSTRUCTURED LIPID CARRIERS IN COSMECEUTICALS

  year unknowncites this paper